Angélica Lucero Ortiz-Córdoba

Angélica Lucero Ortiz-Córdoba

Auto-generated profile, based on publicly available information

Angélica Lucero Ortiz-Córdoba

Fundación Universitaria, Colombia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in ASAIO Journal
Verified
Journal Article
Closed access
LSLeonardo Salazar
Leonardo Salazar
ABAnderson Bermon
Anderson Bermon
RVRaul Vasquez
Raul Vasquez
MCMario Castillo
Mario Castillo
AMAlejandra Mendoza-Monsalve
Alejandra Mendoza-Monsalve
CPCamilo E. Pizarro
Camilo E. Pizarro
Veno-venous extracorporeal membrane oxygenation (ECMO) support surged during the COVID-19 pandemic. Our program changed the model of care pursuing to protect the multidisciplinary team from the risk of infection and to serve as many patients as possible. Patient–healthcare interactions were restricted, and the ECMO bed capacity was increased by reducing the ECMO specialist–patient ratio to 1:4 with non-ECMO trained nurses support. The outcomes worsened and we paused while we evaluated and modified our model of care. The ECMO bed capacity was reduced to allow a nurse ECMO–specialist nurse ratio 2:1 with an ECMO trained nurse assistant’s support. Intensivists, general practitioners, nurse assistants, and physical and respiratory therapists were trained on ECMO. Tracheostomy, bronchoscopy, and microbiological molecular diagnosis were done earlier, and family visits and rehabilitation were allowed in the first 48 hours of ECMO cannulation. There were 35 patients in the preintervention cohort and 66 in the postintervention cohort. Ninety days mortality was significantly lower after the intervention (62.9% vs. 31.8%, p = 0.003). Factors associated with increased risk of death were the need for cannulation or conversion to veno arterial or veno arterio venous ECMO, hemorrhagic stroke, and renal replacement therapy during ECMO. The interventions associated with a decrease in the risk of death were the following: early fiberoptic bronchoscopy and microbiological molecular diagnostic tests. Increasing the ECMO multidisciplinary team in relation to the number of patients and the earlier performance of diagnostic and therapeutic interventions, such as tracheostomy, fiberoptic bronchoscopy, molecular microbiological diagnosis of pneumonia, rehabilitation, and family support significantly decreased mortality of patients on ECMO due to COVID-19.

1 January 2026 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
GCGianmarco Camelo-Pardo
Gianmarco Camelo-Pardo
AMAlejandra Mendoza-Monsalve
Alejandra Mendoza-Monsalve
MLMaricel Licht
Maricel Licht
AOAngélica Lucero Ortiz-Córdoba
Angélica Lucero Ortiz-Córdoba
JAJosé Rafael Almarales-Navarro
José Rafael Almarales-Navarro
EMEdgar Fabián Manrique-Hernández
Edgar Fabián Manrique-Hernández
Objective: The aim of this study was to assess the cost-effectiveness of early versus late initiation of extracorporeal membrane oxygenation (ECMO) in pediatric patients with acute respiratory distress syndrome admitted to the intensive care unit. Methods: A cost-effectiveness analysis was conducted from the hospital provider perspective, comparing early (≤7 days) versus late (>7 days) initiation of ECMO. Direct medical costs and 90-day survival were incorporated into a decision tree to estimate the incremental cost-effectiveness ratio. Deterministic and probabilistic sensitivity analyses were performed using a willingness-to-pay threshold equivalent to three times the Colombian gross domestic product per capita. Results: Among 78 patients, most patients received early ECMO initiation, and this strategy was associated with similar mortality and comparable total direct medical costs compared with late initiation. Probabilistic simulations indicated a higher probability of cost-effectiveness for early initiation across different willingness-to-pay thresholds. Cost parameters were the main drivers of variability in the incremental cost-effectiveness ratio. Conclusions: No statistically significant differences were observed between early and late ECMO initiation in survival or costs. A possible economic trend favoring early initiation should be interpreted cautiously, given limited statistical power.

6 November 2025 in Pediatric Transplantation
Verified
Journal Article
Closed access
JCJavier Castro
Javier Castro
MAMelina Acevedo
Melina Acevedo
AOAngelica Ortiz
Angelica Ortiz
JBJuliana Ballesteros
Juliana Ballesteros
SPSilvia Plata
Silvia Plata
LSLeonardo Salazar
Leonardo Salazar